This post was originally published on this site
The world’s largest health products company in November announced it would spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest shake-up in its 135-year history.
Mongon currently serves as the executive vice president and worldwide chairman of the company’s consumer health division after joining the company in 2000.
J&J also appointed the chief financial officer of the consumer health business Paul Ruh as the CFO of the upcoming entity.
The leadership transition would occur after the separation completes, which is expected to happen within 2023, subject to legal requirements, the company said.
